Broad Spectrum Monitoring vs. Biomarkers: Clinical Needs in an All-Cause Readmission Environment
The medical establishment today is confined in its approach towards physiological monitoring based on time-honored biomarkers, procedures and therapies – that is, point solutions for specific diseases. To many of us, as engineers and scientists not...
Read More